This correlates well with the presence of Aβ1-42 in the cerebrospinal fluid (CSF) and induction of tau level in the CSF, and therefore, white matter abnormality begins several years ahead of the clinical manifestation of AD in humans [122,123]. Here, MAPT is linked to Alzheimer disease.